Phase I trial of RGB 286638 in patients with solid tumours.

Trial Profile

Phase I trial of RGB 286638 in patients with solid tumours.

Recruiting
Phase of Trial: Phase I

Latest Information Update: 14 Jul 2014

At a glance

  • Drugs RGB 286638 (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions; First in man
  • Most Recent Events

    • 09 Dec 2008 Status changed from planning to recruiting according to a GPC Biotech media release.
    • 28 Feb 2008 This trial is expected to begin within the next 6 months.
    • 28 Feb 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top